Literature DB >> 11241301

Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions.

A J Miga1, S R Masters, B G Durell, M Gonzalez, M K Jenkins, C Maliszewski, H Kikutani, W F Wade, R J Noelle.   

Abstract

Inflammatory mediators facilitate the maturation of dendritic cells (DC), enabling them to induce the activation, proliferation and differentiation of cognate T cells. The role of CD40 on DC and CD154 on T cells has been studied by the co-adoptive transfer of antigen-pulsed DC and TCR-transgenic (Tg) T cells in vivo. It is shown that in the absence of CD40-CD154 interactions, initial Tg T cell expansion occurs in vivo, but over time, T cell expansion cannot be sustained. The basis for the demise of the T cell population is likely due to the disappearance of the antigen-pulsed DC in the draining lymph nodes when CD154-CD40 interactions are interrupted. These findings show that both T cell and DC persistence in vivo is dependent on CD40-CD154 interactions. In addition to the physical persistence of the DC, CD40 triggering of DC also greatly increases the period for which they can productively present antigen to Tg T cells. Hence DC persistence and antigen-presenting cell capacity are both dependent on CD40 signaling. While TNF-alpha can mature DC as measured by a variety of criteria, the unique capacity of CD40 signaling to sustain T cell responses and induce DC maturation is underscored by the inability of TNF-alpha to rescue the immune deficiency of CD40(-/-) DC. Hence, the profound impact of CD154 deficiency on cell-mediated immunity may be due to its ability to limit the duration of antigen presentation in vivo and cause the premature demise of antigen-specific T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241301     DOI: 10.1002/1521-4141(200103)31:3<959::aid-immu959>3.0.co;2-a

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions.

Authors:  Rui Zhang; Jeffrey D Lifson; Claire Chougnet
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

Review 2.  New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.

Authors:  Marc Scherlinger; Vanja Sisirak; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

3.  Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation.

Authors:  Reinhard Obst; Hisse-Martien van Santen; Rachel Melamed; Alice O Kamphorst; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

4.  Immunological synapse formation inhibits, via NF-kappaB and FOXO1, the apoptosis of dendritic cells.

Authors:  Lorena Riol-Blanco; Cristina Delgado-Martín; Noelia Sánchez-Sánchez; Luis M Alonso-C; María Dolores Gutiérrez-López; Gloria Martínez Del Hoyo; Joaquín Navarro; Francisco Sánchez-Madrid; Carlos Cabañas; Paloma Sánchez-Mateos; José Luis Rodríguez-Fernández
Journal:  Nat Immunol       Date:  2009-06-07       Impact factor: 25.606

5.  Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.

Authors:  Jungsun Park; Haiyan Li; Mingjun Zhang; Yong Lu; Bangxing Hong; Yuhuan Zheng; Jin He; Jing Yang; Jianfei Qian; Qing Yi
Journal:  Cancer Immunol Immunother       Date:  2014-05-20       Impact factor: 6.968

Review 6.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

7.  Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells.

Authors:  Michael Y Gerner; Matthew F Mescher
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Macrophage effector responses of horses are influenced by expression of CD154.

Authors:  Brett A Sponseller; Sandra K Clark; Jessica Gilbertie; David M Wong; Kate Hepworth; Sarah Wiechert; Prashanth Chandramani; Beatrice T Sponseller; Cody J Alcott; Bryan Bellaire; Andrew C Petersen; Douglas E Jones
Journal:  Vet Immunol Immunopathol       Date:  2016-08-26       Impact factor: 2.046

9.  Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses.

Authors:  Michael Y Gerner; Kerry A Casey; Matthew F Mescher
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity.

Authors:  Brian M Janelsins; Alicia R Mathers; Olga A Tkacheva; Geza Erdos; William J Shufesky; Adrian E Morelli; Adriana T Larregina
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.